BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33597362)

  • 41. [A Case of Advanced Hepatocellular Carcinoma Successfully Treated with Liver Resection after Administration of Sorafenib].
    Kodai S; Kanazawa A; Kinoshita M; Hamano G; Nishio K; Murata A; Shimizu S; Kikuchi T; Yonemitsu K; Shirai D; Nobori C; Tashima T; Goto W; Miura K; Maeda K
    Gan To Kagaku Ryoho; 2020 Mar; 47(3):502-504. PubMed ID: 32381929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of Sorafenib and Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Study.
    Shiozawa K; Watanabe M; Ikehara T; Kogame M; Matsui T; Okano N; Kikuchi Y; Nagai H; Ishii K; Makino H; Igarashi Y; Sumino Y
    Hepatogastroenterology; 2014 Jun; 61(132):885-91. PubMed ID: 26158136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A case of curative resection for advanced hepatocellular carcinoma with portal vein tumor thrombus after hepatic arterial infusion chemotherapy].
    Ishizaki M; Kaibori M; Matsui K; Nakatake R; Matsushima H; Sakaguchi T; Kwon AH
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1991-3. PubMed ID: 23267953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis.
    He MK; Zou RH; Li QJ; Zhou ZG; Shen JX; Zhang YF; Yu ZS; Xu L; Shi M
    Cardiovasc Intervent Radiol; 2018 May; 41(5):734-743. PubMed ID: 29327075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy.
    Shao YY; Liang PC; Wu YM; Huang CC; Huang KW; Cheng JC; Hsu CH; Hsu C; Cheng AL; Lin ZZ
    Liver Int; 2013 Oct; 33(9):1413-9. PubMed ID: 23714197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant hepatic arterial infusional chemotherapy with 5-fluorouracil and cisplatin after curative resection of hepatocellular carcinoma.
    Kim DY; Ahn SH; Kim SU; Choi SB; Lee KH; Park MS; Park JY; Lee DY; Han KH; Kim KS
    Oncology; 2011; 81(3-4):184-91. PubMed ID: 22067673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Kanekawa T; Nagai H; Kanayama M; Sumino Y
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):899-909. PubMed ID: 25138286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
    Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M
    Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Successful treatment of metastatic hepatocellular carcinoma with sorafenib combined with transcatheter arterial chemoembolization/hepatic arterial infusion chemotherapy].
    Watanabe Y; Nakaba H; Taniguchi E; Kikkawa H; Tamagawa H; Sasaki M; Kitayama T; Doi Y; Oguchi Y
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2110-2. PubMed ID: 25731439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic arterial thrombosis: a critical complication during combination therapy of arterial chemoinfusion and sorafenib.
    Nishiofuku H; Tanaka T; Anai H; Sueyoshi S; Maeda S; Masada T; Kichikawa K
    Anticancer Res; 2012 Sep; 32(9):4121-4. PubMed ID: 22993371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A case of hepatocellular carcinoma responding to hepatic arterial infusion chemotherapy with low-dose cisplatin and 5-fluorouracil].
    Takeda Y; Hasuike Y; Tsujinaka T
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1712-7. PubMed ID: 11708016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Successful treatment for advanced hepatocellular carcinoma by hepatic arterial infusion of CDDP powder as second-line chemotherapy].
    Gen Y; Kimura H; Akitake R; Sakai A; Fukui A; Takao T; Ikezawa S; Masuda A; Takashima H; Funatsu E; Nakamura H; Okuyama Y; Arai M; Yagi N; Kutsumi H; Fujimoto S; Takeuchi Y
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):505-8. PubMed ID: 16612162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The effect of sorafenib and intermittent hepatic arterial infusion chemotherapy using cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombus--a pilot study].
    Ishizaki M; Kaibori M; Matsui K; Yanagimoto Y; Nakatake R; Kwon AH
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2679-82. PubMed ID: 21224678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Eun JR; Lee HJ; Moon HJ; Kim TN; Kim JW; Chang JC
    Scand J Gastroenterol; 2009; 44(12):1477-86. PubMed ID: 19958061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis.
    Hu J; Bao Q; Cao G; Zhu X; Yang R; Ji X; Xu L; Zheng K; Li W; Xing B; Wang X
    Cardiovasc Intervent Radiol; 2020 Jul; 43(7):996-1005. PubMed ID: 31974744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma.
    Shao YY; Huang CC; Liang PC; Lin ZZ
    Asia Pac J Clin Oncol; 2010 Jun; 6(2):80-8. PubMed ID: 20565419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A case of Vp4 hepatocellular carcinoma treated with surgical resection and continuous intrahepatic artery infusion chemotherapy of low-dose cisplatin and 5-fluorouracil].
    Tamesa T; Mori N; Okada T; Takemoto N; Sakamoto K; Yamasaki T; Tangoku A; Oka M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1769-72. PubMed ID: 14619515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: a propensity score-based weighting.
    Kondo M; Morimoto M; Ishii T; Nozaki A; Fukuda H; Numata K; Kobayashi S; Ohkawa S; Hidaka H; Nakazawa T; Shibuya A; Okuse C; Suzuki M; Sakamaki K; Morita S; Maeda S; Tanaka K
    J Dig Dis; 2015 Mar; 16(3):143-51. PubMed ID: 25495751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy.
    Meric F; Patt YZ; Curley SA; Chase J; Roh MS; Vauthey JN; Ellis LM
    Ann Surg Oncol; 2000 Aug; 7(7):490-5. PubMed ID: 10947016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Response to chemotherapy improves hepatic reserve for patients with hepatocellular carcinoma and Child-Pugh B cirrhosis.
    Terashima T; Yamashita T; Arai K; Kawaguchi K; Kitamura K; Yamashita T; Sakai Y; Mizukoshi E; Honda M; Kaneko S
    Cancer Sci; 2016 Sep; 107(9):1263-9. PubMed ID: 27315783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.